But the shitty part is, these companies make back their R&D investment in a year, if not sooner. They still charge up the ass for it. So they have zero sympathy from me.It looks like he claimed there was a deal to make ozempic cost $150, but there isn't, at least not yet.
I have mixed feelings about the prices falling. Obviously I want more people to be able to afford these drugs. But without huge profit margins, it's not clear we'll get the same level of innovation we've come to expect. Yes, retatrutide and tirzepatide are awesome, but they cost billions to develop, and if we want more innovation like that, there needs to be billions more for the taking.
I think the best outcome would be that the government doesn't negotiate any such deal, Americans keep paying through the nose for few more years for peptides, and new entrants like Boehringer Ingelheim, Roche, and Viking add competitive pressure so the prices of sema, tirz, and eventually reta are forced down. Ozempic list won't fall to $150, but more PBMs/policies will cover it with reasonable copay.
It doesn’t look like there’s actually any confirmed deal to make Ozempic $150 — that seems to be more rumor than reality for now.It looks like he claimed there was a deal to make ozempic cost $150, but there isn't, at least not yet.
I have mixed feelings about the prices falling. Obviously I want more people to be able to afford these drugs. But without huge profit margins, it's not clear we'll get the same level of innovation we've come to expect. Yes, retatrutide and tirzepatide are awesome, but they cost billions to develop, and if we want more innovation like that, there needs to be billions more for the taking.
I think the best outcome would be that the government doesn't negotiate any such deal, Americans keep paying through the nose for few more years for peptides, and new entrants like Boehringer Ingelheim, Roche, and Viking add competitive pressure so the prices of sema, tirz, and eventually reta are forced down. Ozempic list won't fall to $150, but more PBMs/policies will cover it with reasonable copay.
I know plenty of merchants who sell it for less.
When they succeed in creating a blockbuster drug (something that usually doesn't happen), then they make up their research and development costs quickly. They often lose money on drugs that either are not approved or do get approved but then don't sell.But the shitty part is, these companies make back their R&D investment in a year, if not sooner. They still charge up the ass for it. So they have zero sympathy from me.
There are some things about these company's "innovations" that are vastly misrepresented, and the propaganda that we can't have the same level of innovation if they weren't allowed to gouge the American health system is a major fallacy.It looks like he claimed there was a deal to make ozempic cost $150, but there isn't, at least not yet.
I have mixed feelings about the prices falling. Obviously I want more people to be able to afford these drugs. But without huge profit margins, it's not clear we'll get the same level of innovation we've come to expect. Yes, retatrutide and tirzepatide are awesome, but they cost billions to develop, and if we want more innovation like that, there needs to be billions more for the taking.
I think the best outcome would be that the government doesn't negotiate any such deal, Americans keep paying through the nose for few more years for peptides, and new entrants like Boehringer Ingelheim, Roche, and Viking add competitive pressure so the prices of sema, tirz, and eventually reta are forced down. Ozempic list won't fall to $150, but more PBMs/policies will cover it with reasonable copay.
Nah.But the shitty part is, these companies make back their R&D investment in a year, if not sooner.
This isn’t true.When they succeed in creating a blockbuster drug (something that usually doesn't happen), then they make up their research and development costs quickly.
Oh ok...cool. Thanks for elaborating on that.Nah.
It’s just not true. It took decades to develop and approve the first two generations of GLP-1s.Oh ok...cool. Thanks for elaborating on that.